Evidence that the mechanisms of fungitoxicity of 8-quinolinol and its bischelate with copper(II) are different.
The copper(II) contents of the growth media, Sabouraud dextrose and Czapek-Dox broths, and of the spore inocula of Aspergillus niger (ATCC 1004), Aspergillus oryzae (ATCC 1011), Trichoderma viride (ATCC 8678), and Myrothecium verrucaria (ATCC 9095) were determined by atomic absorption spectrophotometry in a graphite furnace. The test systems composed of Sabouraud dextrose broth and spore inocula of the four fungi contained only a little over 3% of the copper(II) required to form a minimal inhibitory concentration of bis(8-quinolinolato)copper(II). The test system of Czapek-Dox broth and A. oryzae contained slightly less than 65% of the copper(II) required to form a minimal inhibitory concentration of the bischelate of 8-quinolinol with copper(II). When the minimal inhibitory concentrations of 8-quinolinol and bis(8-quinolinolato)copper(II) were added simultaneously to the test system of Czapek-Dox broth and A. oryzae, 10% of the combined mixture of toxicants caused complete inhibition of growth indicating synergism between the toxicants. These results together with the observation that alpha-lipoic acid as well as small aliphatic thiol-containing compounds (cysteine, glutathione, dithioerythritol, and dithiothreitol) reversed the toxicity of 8-quinolinol but not the toxicity of bis(8-quinolinolato)copper(II) led to the conclusion that the mechanisms of fungitoxicity of both toxicants are different.
D001230:Aspergillus / Q000187:drug effects*; D001234:Aspergillus niger / Q000032:analysis / Q000187:drug effects / Q000254:growth & development; D001236:Aspergillus oryzae / Q000032:analysis / Q000187:drug effects / Q000254:growth & development; D002614:Chelating Agents; D003300:Copper / Q000032:analysis* / Q000494:pharmacology*; D003470:Culture Media; D006912:Hydroxyquinolines / Q000494:pharmacology*; D003904:Mitosporic Fungi / Q000032:analysis / Q000187:drug effects* / Q000254:growth & development; D009942:Organometallic Compounds; D015125:Oxyquinoline / Q000031:analogs & derivatives / Q000494:pharmacology*; D013172:Spores, Fungal / Q000032:analysis / Q000254:growth & development; D014242:Trichoderma / Q000032:analysis / Q000187:drug effects / Q000254:growth & development
D002614:Chelating Agents; D003470:Culture Media; D006912:Hydroxyquinolines; D009942:Organometallic Compounds; C047488:bis(8-quinolinolato)copper(II); D015125:Oxyquinoline; D003300:Copper